Blood cancer

Groundbreaking Israeli treatment may offer cure for blood cancer

“We are reprogramming another type of the immune system’s cells called T-cells, in order to teach them to fight the cancer inside the blood of the patient.”

Cell therapy co. Gamida Cell announces USD 75 m. financing

Gamida Cell is a cell therapy company working to develop and commercialize cures for blood cancers and blood diseases.

When completed, Magen David Adom’s new Marcus National Blood Services Center will more than double I


American donors to Magen David Adom are building a new blood center for Israel to ensure there’s blood for civilians and soldiers when it’s needed most.

Red blood cells (illustrative)

Israeli-American Gamida hits goal in phase 3 blood cancer trial

The company uses umbilical cord blood, which like bone marrow and peripheral blood, is a rich source of stem cells for transplantation.

Tel Aviv University researchers (from left): Dr. Yaron Carmi, Diana Rasuluniriana, Dr. Peleg Ride

Israeli blood cancer treatment could also kill solid tumors - new study

Lead researcher Dr. Yaron Carmi believes that the treatment will be available within two years for human trials and compassionate use.

Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy